603108.SH
润达医疗
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 9.55
−3.24%Margins
Gross margin
21.9%
EBITDA margin
-1.7%
EBIT margin
-6.4%
Net margin
-7.8%
FCF margin
4.4%
-14.3%
Return on equity
-4.1%
Return on assets
-4.8%
Return on invested capital
0.52x
Asset turnover
CNY 566.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026